Navigation Links
Pharmos Corporation Reports Second Quarter 2012 Results
Date:7/30/2012

ISELIN, N.J., July 30, 2012 /PRNewswire/ -- Pharmos Corporation (OTCQB: PARS) today reported financial results for the second quarter and six-month period ended June 30, 2012. These results are included in the Company's Quarterly Report on Form 10-Q which has been filed with the SEC.

In May the Company issued a press release announcing the successful completion of a proof-of concept trial of levotofisopam for the treatment of gout. The trial was open label and 100% of the subjects were responders bringing their serum acid levels below 6mg/dL and 54% achieved serum uric acid levels below 4mg/dL. The Company has very limited financial resources and therefore needs to secure a partnership or raise additional capital to further develop levotofisopam.

Liquidity and Cash positionThe Company's condensed consolidated financial statements have been prepared assuming it will continue as a going concern. At June 30, 2012, the Company had approximately $0.5 million in cash and cash equivalents. Management believes that the current cash and cash equivalents will be sufficient to support their currently planned continuing operations through October 2012. Currently the Company spends approximately $100,000 a month on continuing operating expenses. The Company has a debenture of $1 million due to be repaid on November 1, 2012 which the Company will be unable to satisfy unless it achieves a collaboration with a pharmaceutical partner or raises additional capital to advance its lead compounds, levotofisopam, for the treatment of Gout, and dextofisopam, for the treatment of IBS.

Second Quarter Ended June 30, 2012The Company recorded a net loss of $0.4 million, or ($0.01) per share, for the second quarter 2012 compared to a net loss of $0.5 million, or ($0.01) per share, in the second quarter 2011. 

Research & development expenses for the second quarter decreased by $99,613, or 46%, from $214,470 in 2011 to $114,857 in 2012. The primary areas i
'/>"/>

SOURCE Pharmos Corporation
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. United Therapeutics Corporation Reports Second Quarter 2012 Financial Results
2. Verenium Corporation And Alexandria Real Estate Equities, Inc. Celebrate The Grand Opening Of A New State-of-the-art Biotechnology Facility
3. United Therapeutics Corporation to Announce Second Quarter 2012 Financial Results Before Market Open on Thursday, July 26, 2012
4. Neogen Corporation Announces Year-End Results Conference Call
5. Verenium Corporation Named One Of The 2012 Best Places to Work in San Diego
6. Ethical Corporation Names Life Technologies First CSO Sustainability Executive of the Year
7. TREVENTIS Corporation Scientific Founder, Donald Weaver, MD, Named Sobey Chair in Alzheimers Disease Research, His Third Endowed Chair
8. China Cord Blood Corporation Continues Share Repurchase Program
9. Triple-S Management Corporation Announces the Retirement of Socorro Rivas-Rodriguez; Names Pablo Almodovar Scalley as Successor
10. Berkshire Corporation Offers Live Chat For Americas Website and Shopping Cart
11. ATCC Announces Agreement with Life Technologies Corporation to Sell and Distribute Green Fluorescent Protein (GFP)-based Materials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... succeeded in measuring vibrational motion of a single molecule ... vibration of a single molecule differs from the behaviour ... performed at the University of California, Irvine, where post-doctoral ... as a visiting fellow under professor Vartkess A. Apkarian, ... was lead by Professor Eric O. Potma. The results ...
(Date:8/20/2014)... BOSTON , Aug. 20, 2014  PAREXEL International ... it will be presenting at the Baird Healthcare Conference ... President and Chief Financial Officer, will be making a ... p.m. EDT on Wednesday, Sept. 3, 2014. ... through the "Investors" section of PAREXEL,s website at ...
(Date:8/20/2014)... improve the health of your heart, researchers have discovered. ... a standard TENS machine like those designed to relieve ... the small raised flap at the front of the ... The stimulation changed the influence of the nervous system ... can drive failing hearts too hard. , Professor Jim ...
(Date:8/19/2014)... 19, 2014 Shimadzu Scientific Instruments ... Prominence-i and Nexera-i, adding to the company’s extensive ... functionality, an intuitive operating environment, and full automation, ... efficient workflow for conventional to ultra-high-speed analysis. ... and intelligent design so users can begin building ...
Breaking Biology Technology:Seeing a molecule breathe 2PAREXEL International To Present At Baird Healthcare Conference 2'Tickling' your ear could be good for your heart 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 2Shimadzu’s New i-Series Integrated Liquid Chromatography Systems Provide Laboratories Wider Range of Analytical Capabilities 3
... TROMS0, Norway and SEOUL, Korea, June 19 ... KAEL-GemVax,today announced the signing of a collaborative agreement to ... for the treatment of,cancer. , ... CEO Jay,Sangjae Kim, "We are delighted to announce this ...
... research from Cincinnati Children,s Hospital Medical Center highlights the critical ... embryonic development on formation of a normal heart and skull. ... Proceedings of the National Academy of Sciences , a ... the gene/protein SHP2 interferes with the normal developmental activity of ...
... Inc. (OTC Bulletin Board: GOVX), an Atlanta-based biopharmaceutical ... HIV-1 (Human Immunodeficiency Virus), and other infectious agents, announced ... cooperative arrangement with Cook County Board President Todd H. ... County Health and Hospitals Systems Board ("Health System"); and ...
Cached Biology Technology:Lytix Biopharma and KAEL-GemVax Announce Joint Clinical Trial to Combine LTX-315 and GV1001 Cancer Immunotherapy 2Scientists identify gene vital to early embryonic cells forming a normal heart and skull 2GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 2GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 3GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 4GeoVax Signs HIV/AIDS Vaccine Proposal With Health and Hospital System of Cook County, Illinois 5
(Date:8/21/2014)... AWI geologist Juliane Mller the Fram Strait is a key ... of this passage between Greenland and Svalbard warm Atlantic water ... the west side cold Arctic water masses and sea ice ... Atlantic. A considerable portion of the Atlantic water cools here ... layers. The circulation of the water caused in this manner ...
(Date:8/21/2014)... the journal Carcinogenesis by researchers at the ... protein adenomatous polyposis coli (APC) in suppressing colorectal cancer ... U.S. , Lead author Kristi Neufeld, associate professor in ... Cancer Biology program at the KU Cancer Center, has ... understand the various activities of APC, a protein whose ...
(Date:8/21/2014)... team has successfully replicated one of the crucial steps ... by sunlight which could manufacture hydrogen as a fuel. ... is an exciting prospect to use them to create ... Kastoori Hingorani, from the ARC Centre of Excellence for ... , Hydrogen offers potential as a zero-carbon replacement for ...
Breaking Biology News(10 mins):Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Water and sunlight the formula for sustainable fuel 2
... Early Control of H5N1 Influenza Virus Researchers from ... H5N1 influenza virus replication in mice and may offer some ... They report their findings in the June 2009 issue of ... Highly pathogenic avian influenza H5N1 viruses increasingly pose a serious ...
... Return on Investment with DigitalPersona U.are.U(R) Fingerprint Readers ... DigitalPersona, Inc., a leader in fingerprint identity ... Wendy,s restaurant franchisee, Tar Heel Capital, has chosen ... Heel Capital, which owns 76 Wendy,s franchise locations ...
... and insufficient law enforcement mean that Thailand continues ... Asia, says a new report from the wildlife ... raises concerns that legal provisions governing trade in ... in wild-caught, highly-endangered Asian elephants from both Thailand ...
Cached Biology News:Tips from the journals of the American Society for Microbiology 2Tips from the journals of the American Society for Microbiology 3Tips from the journals of the American Society for Microbiology 4One of the Largest Wendy's(R) Franchisees, Tar Heel Capital, Reduces Fraud and Slashes Costs with DigitalPersona 2Elephant-size loopholes sustain Thai ivory trade 2
... X-Gal ,MOLECULAR BIOLOGY GRADE ,5-Bromo-4-chloro-3-indoxyl-beta-D-galactopyranoside C ... Cl N O 6 ,M.W.= ... ,Solution: Clear (2% in DMF) ,Biological ... and M13 ,Elemental Analysis: Agrees with ...
...
... MW: 34.2kDa Formulation: 10mM HEPES, pH ... dithiothreitiol with 50% glycerol Properites: For ... Certificate of Analysis for individual lots ... followed by gel filtration and Mono-S ...
Antibody Purification Specificity: Antibody Purification ...
Biology Products: